FDA.reportPublic FDA data

maralixibat 19 MG/ML Oral Solution [Livmarli]

RxCUI
2690992
RxNorm name
maralixibat 19 MG/ML Oral Solution [Livmarli]
Display name
maralixibat 19 MG/ML Oral Solution [Livmarli]
Full name
maralixibat 19 MG/ML Oral Solution [Livmarli]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LivmarliMARALIXIBAT CHLORIDEMirum Pharmaceuticals Inc.64000394-1ef6-4e76-8ba8-11f25ba1b1672025-04-10Warnings, Adverse reactionsExact identifier
rxcui: 2690992

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
64000394-1ef6-4e76-8ba8-11f25ba1b167maralixibat 19 MG/ML Oral Solution [Livmarli]SBD11These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 202120250410
64000394-1ef6-4e76-8ba8-11f25ba1b167Livmarli 19 MG/mL Oral SolutionPSN11These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 202120250410
64000394-1ef6-4e76-8ba8-11f25ba1b167Livmarli 19 MG/ML Oral SolutionSY11These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 202120250410